- Home
- SGHT
SGHT
Sight Sciences Inc.
as 09-05-2025 4:00pm EST
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 179.7M | IPO Year: | 2021 |
| Target Price: | $4.29 | AVG Volume (30 days): | 125.0K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.03 - $7.03 | Next Earning Date: | 11-06-2025 |
| Revenue: | $76,303,000 | Revenue Growth: | -3.89% |
| Revenue Growth (this year): | -5.9% | Revenue Growth (next year): | 11.32% |
Latest Sight Sciences Inc. News
SGHT Breaking Stock News: Dive into SGHT Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
Sight Sciences Leads The Pack Of 3 Promising Penny Stocks
Argus Research
3 months ago
Daily – Vickers Top Buyers & Sellers for 05/30/2025
Simply Wall St.
4 months ago
Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential
GlobeNewswire
4 months ago
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th
GuruFocus.com
4 months ago
Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ...
Zacks
4 months ago
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
4 months ago
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
GlobeNewswire
4 months ago
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
Compare SGHT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SGHT Sight Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.